Figure 4. SIFα potentiates the therapeutic effect of Gemcitabin (GEM).

Pancreatic cancer cells ASPC (A) and CFPAC1 (B) were transfected with interferon lentiviruses in the presence of the low dose of GEM. Cell growth was measured by sulforhodamine B (SRB)-assay. All data shown are mean ± SD from three independent. *p < 0.05 as compared with controls and with the wild type IFNα group.